Journal of Jilin University(Medicine Edition) ›› 2020, Vol. 46 ›› Issue (02): 413-418.doi: 10.13481/j.1671-587x.20200235
• Review • Previous Articles
Research progress in clinical application of Raman spectroscopyin breast cancer
-
Received:2019-08-22Published:2020-04-07
CLC Number:
- R737.9
Cite this article
share this article
| [1] BRAY F, FERIAY J,SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in countries[J].CA-Cancer J Clin,2018,68(6):394-424. [2] FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide:Sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer,2015, 136(5):E359-E386. [3] TITLOYE N A, FOSTER A, OMONIYI-ESAN G O, et al. Histological features and tissue microarray taxonomy of nigerian breast cancer reveal predominance of the high-grade triple-negative phenotype[J]. Pathobiology, 2016, 83(1):24-32. [4] TORRE L A, SIEGEL R L, WARD E M, et al. Global cancer incidence and mortality rates and trends-an update[J].Cancer Epidemiol Biomarkers Prev, 2016, 25(1):16-27. [5] EDWARDS B L, ATKINS K A, STUKENBORG G J, et al. The association of mammographic density and molecular breast cancer subtype[J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(10):1487-1492. [6] LI X X, OPREA-ILIES G M, KRISHNAMURTI U. New developments in breast cancer and their impact on daily practice in pathology[J]. Arch Pathol Lab Med, 2017, 141(4):490-498. [7] KONG K, KENDALL C, STONE N, et al. Raman spectroscopy for medical diagnostics——From in-vitro biofluid assays to in-vivo cancer detection[J]. Adv Drug Deliv Rev, 2015, 89:121-134. [8] ALONSO-GONZÁLEZ P, ALBELLA P, SCHNELL M, et al. Resolving the electromagnetic mechanism of surface-enhanced light scattering at single hot spots[J]. Nat Commun, 2012, 3:684. [9] KUKUSHKIN V I, VAN'KOV A B, KUKUSHKIN I V. Long-range manifestation of surface-enhanced Raman scattering[J]. JETP Lett,2013, 98(2):64-69. [10] SINGH A K, KHAN S A, FAN Z, et al. Development of a long-range surface-enhanced Raman spectroscopy ruler[J].Am Chem Soc, 2012, 134(20):8662-8669. [11] DIERINGER J A, MCFARLAND A D, SHAH N C, et al. Surface enhanced Raman spectroscopy:new materials, concepts, characterization tools, and applications[J]. Faraday Discuss, 2006, 132(6):9-26. [12] DA SILVA MARTINS M A, RIBEIRO D G, PEREIRA DOS SANTOS E A, et al. Shifted-excitation Raman difference spectroscopy for in vitro and in vivo biological samples analysis[J]. Biomed Optics Express, 2010, 1(2):617-626. [13] DE LUCA A C, MAZILU M, RICHES A, et al. Online fluorescence suppression in modulated Raman spectroscopy[J]. Anal Chem, 2010, 82(2):738-745. [14] GEBREKIDAN M T, ERBER R, HARTMANN A, et al. Breast tumor analysis using shifted-excitation Raman difference spectroscopy (SERDS)[J]. Technol Cancer Res Treat, 2018, 17:1533033818782532. [15] CAMP C H, LEE Y J, HEDDLESTON J M, et al. High-speed coherent Raman fingerprint imaging of biological tissues[J]. Nat Photonics, 2014, 8(6):627-634. [16] MATOUSEK P. Deep non-invasive Raman spectroscopy of living tissue and powders[J]. Che Soc Rev, 2007, 36(8):1292-1304. [17] MATOUSEK P, STONE N. Development of deep subsurface Raman spectroscopy for medical diagnosis and disease monitoring[J]. Chem Soc Rev, 2016, 45(7):1794-1802. [18] KELLER M D, WILSON R H, MYCEK M A, et al. Monte Carlo model of spatially offset Raman spectroscopy for breast tumor margin analysis[J]. Appl Spectrosc, 2010, 64(6):607-614. [19] ELLIS D I, ECCLES R, XU Y, et al. Through-container, extremely low concentration detection of multiple chemical markers of counterfeit alcohol using a handheld SORS device[J]. Sci Rep, 2017, 7(1):12082. [20] SOWOIDNICH K, CHURCHWELL J H, BUCKLEY K, et al. Spatially offset Raman spectroscopy for photon migration studies in bones with different mineralization levels[J]. Analyst, 2017, 142(17):3219-3226. [21] NICOLSON F, JAMIESON L E, MABBOTT S, et al. Through tissue imaging of a live breast cancer tumour model using handheld surface enhanced spatially offset resonance Raman spectroscopy (SESORRS)[J]. Chem Sci, 2018, 9(15):3788-3792. [22] SCHMADEKA R, HARMON B E, SINGH M. Triple-negative breast carcinoma current and emerging concepts[J]. Am J Clin Pathol, 2014, 141(4):462-477. [23] MINN A J, GUPTA G P, SIEGEL P M, et al. Genes that mediate breast cancer metastasis to lung[J]. Nature, 2005, 436(7050):518-524. [24] MANCIU F S, CIUBUC J D, PARRA K, et al. Label-free Raman imaging to monitor breast tumor signatures[J]. Technol Cancer Res Treat, 2017, 16(4):461-469. [25] LEE S H, KIM O K, LEE S, et al. Local-dependency of morphological and optical properties between breast cancer cell lines[J]. Spectrochim Acta A Mol Biomol Spectrosc, 2018, 205:132-138. [26] RICHTER L, WANG Y Q, HYDE R K. Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia[J]. Oncotarget, 2016, 7(40):66255-66266. [27] HUANG R Y, REARDON D A. Imaging studies in immunotherapy[M]. Translational Immunotherapy Brain Tumors.Amsterdam:Elservier,2017:149-179. [28] KORKAYA H, DAVIS A, WICHA M S. Cancer stem cells and the microenvironment[M]. Mol Basis Cancer,2014,8(3):210-218. [29] MARRO M, NIEVA C, DE JUAN A, et al. Unravelling the metabolic progression of breast cancer cells to bone metastasis by coupling Raman spectroscopy and a novel use of mcr-als algorithm[J]. Analyt Chem, 2018, 90(9):5594-5602. [30] MIGNOLET A, WOOD B R, GOORMAGHTIGH E. Intracellular investigation on the differential effects of 4 polyphenols on MCF-7 breast cancer cells by Raman imaging[J]. Analyst, 2017, 143(1):258-269. [31] SHASHNI B, HORIGUCHI Y, KUROSU K, et al. Application of surface enhanced Raman spectroscopy as a diagnostic system for hypersialylated metastatic cancers[J]. Biomaterials, 2017, 134:143-153. [32] HEDEGAARD M, KRAFFT C, DITZEL H J, et al. Discriminating isogenic cancer cells and identifying altered unsaturated fatty acid content as associated with metastasis status, using k-means clustering and partial least squares-discriminant analysis of Raman maps[J]. Anal Chem, 2010, 82(7):2797-2802. [33] ABRAMCZYK H, SURMACKI J, KOPEC M, et al. Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231[J]. Analyst, 2016, 141(19):5646-5658. [34] MATTHEWS Q, JIRASEK A, LUM J J, et al. Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy[J]. Phys Med Biol, 2011, 56(21):6839-6855. [35] ABRAMCZYK H, SURMACKI J, KOPEC M, et al. The role of lipid droplets and adipocytes in cancer. Raman imaging of cell cultures:MCF10A, MCF7, and MDA-MB-231 compared to adipocytes in cancerous human breast tissue[J]. Analyst, 2015, 140(7):2224-2235. [36] BI X H, REXER B, ARTEAGA C L, et al. Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy[J]. J Biomed Opt, 2014, 19(2):025001. [37] HAN B, DU Y, FU T, et al. Differences and relationships between normal and atypical ductal hyperplasia, ductal carcinoma in situ, and invasive ductal carcinoma tissues in the breast based on Raman spectroscopy[J]. Appl Spectrosc, 2017, 71(2):300-307. [38] BROZEK-PLUSKA B, MUSIAL J, KORDEK R, et al. Raman spectroscopy and imaging:applications in human breast cancer diagnosis[J]. Analyst, 2012, 137(16):3773-3780. [39] SURMACKI J, MUSIAL J, KORDEK R, et al. Raman imaging at biological interfaces:applications in breast cancer diagnosis[J]. Mol Cancer, 2013, 12(6):4-8. [40] ABRAMCZYK H, BROZEK-PLUSKA B, SURMACKI J, et al. Raman ‘optical biopsy’ of human breast cancer[J]. Prog Biophys Mol Biol, 2012, 108(1/2):74-81. [41] HAKA A S, VOLYNSKAYA Z, GARDECKI J A, et al. Diagnosing breast cancer using Raman spectroscopy:prospective analysis[J].J Biomed Opt, 2009,14(5):054023. [42] SHIPP D W, RAKHA E A, KOLOYDENKO A A, et al. Intra-operative spectroscopic assessment of surgical margins during breast conserving surgery[J]. Breast Cancer Res, 2018, 20(1):69. [43] HAKA A S, VOLYNSKAYA Z, GARDECKI J A, et al. In vivo margin assessment during partial mastectomy breast surgery using Raman spectroscopy[J]. Cancer Res, 2006, 66(6):3317-3322. [44] ABRAMCZYK H, BROZEK-PLUSKA B. Raman imaging in biochemical and biomedical applications. diagnosis and treatment of breast cancer[J]. Chem Rev, 2013, 113(8):5766-5781. [45] HANLON E B, MANOHARAN R, KOO T W, et al. Prospects for in vivo Raman spectroscopy[J]. Phys Med Biol, 2000, 45(2):R1-R59. [46] NIJSSEN A, KOLJENOVIC S, BAKKER SCHUT T C, et al. Towards oncological application of Raman spectroscopy[J]. Biophotonics, 2009, 2(1/2):29-36. [47] ABRAMCZYK H, BROZEK-PLUSKA B, SURMACKI J, et al. The label-free Raman imaging of human breast cancer[J]. J Mol Liq, 2011, 164(1/2):123-131. [48] REHMAN S, MOVASAGHI Z, TUCKER A T, et al. Raman spectroscopic analysis of breast cancer tissues:identifying differences between normal, invasive ductal carcinoma and ductal carcinoma in situ of the breast tissue[J]. J Raman Spectrosc, 2007, 38(10):1345-1351. |
| [1] | ZHU Zhongbo, QIAN Jiansheng, YANG Shuo, LI Kangle, DOU Jianwei. Inhibitory effect of different doses of 125I seed implantation on tumor-bearing proliferation in nude mice with breast cancer and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1305-1309. |
| [2] | ZHOU Chun, WANG Guanghua, ZHANG Bangzhu. Effects of miR-367 on proliferation, invasion and migration of human breast cancer MCF-7 cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1353-1360. |
| [3] | YANG Zhuangqing, LU Mei, YANG Xiaojuan, WANG Chang'an, ZOU Jieya. Inhibitory effect of inhibiting TRIM24 gene expression on proliferation, apopotosis,invasion and migration of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1379-1383. |
| [4] | YU Xiuyan, WAN Guangcai, SUN Hongshuai, ZHU Hua, GAO Haiyan, WU Xuefeng. Relationship between fibrinogen and prognosis of breast cancer patients:A Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1092-1097. |
| [5] | TAN Qi, REN Liqun, ZHANG Yibing, WANG Yadi, GU Zehui, HUANG Peng, CHEN Suxian. Application of bioinformatics in screening of miRNA biomarkers in triple-negative breast cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1098-1105. |
| [6] | WANG Shuang, KANG Lihua, GUAN Meng, WANG Lei, LI Beibei, ZHAO Yue, SONG Yanqiu, YANG Tingting. Clinical application of apatinib mesylate combined with chemotherapy in treatment of patients with advanced breast cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1152-1158. |
| [7] | XIN Rui, LI Dong, XU Huiying, WANG Chunyu, QU Danhua, SUN Haifeng. Influence of miRNA-21 in radiosensitivity of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 772-778. |
| [8] | . Research progress in clinical application of endocrine therapy for HR+HER2-advanced breast cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 736-741. |
| [9] | SHANG Yanhong, PAN Yuchen, JIA Zhifang, WANG Yueqi, YANG Na, ZHAO Dan, JIANG Jing. Detection of expression levels of miR200 family in plasma of breast cancer patients and its significance [J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 383-388. |
| [10] | . Research progress in relationships between calcification in breast cancer and its clinical, pathological features and prognosis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 450-456. |
| [11] | YU Xiuyan, ZHANG Xiaowei, CONG Zhanjie, LI Ting, WU Xuefeng. Detection of serum hMAM and CD147 levels of patients with breast cancer and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1269-1274. |
| [12] | ZHANG Ping, ZHOU Jia, TANG Yan, LIU Hongyu. Preparation of PR-SPIO-PLGA molecular probe and its property [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1307-1311. |
| [13] | ZHENG Fang, OUYANG Zhengren, OUYANG Jinglin, ZHOU Shili, LUO Wen. Analysis on correlations between ultrasound features and positive expressions of CerbB-2and Ki-67 in patients with breast cancer [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1073-1077. |
| [14] | LI Xiao, QIU Xiang, MA Zhenhui, TIAN Yaping. Skin metastatic carcinoma complicated with herpes zoster:A case report and literature review [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 825-827. |
| [15] | MA Hongyun, ZHUANG Xinming, XU Weiguo, LIU Yi. Inhibitory effects of hyaluronic acid nanoparticles loading doxorubicin and cisplatin on allograft breast cancer in mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 243-248. |
|
||